Pharma news
Americas
Sandoz has brought to market its generic pregabalin product with a full label in the UK and a skinny label in France. Varuni Paranavitane of Osborne Clarke reports on court rulings in the UK, and most recently France, on actions brought by Warner-Lambert against Sandoz. 26 November 2015
Americas
Hedge fund manager Kyle Bass has requested that the Patent and Trial and Appeal Board review the validity of a patent owned by Alpex Pharma. 25 November 2015
Africa
Authorities in Kenya have destroyed more than 65,000 kilos of counterfeit drugs, valued at more than KSh40 million. 25 November 2015
Americas
Pharmaceutical company Pfizer has completed a $160 billion acquisition of generics company Allergan. 23 November 2015
Americas
The proliferation of brands, combined with the financial and PR consequences of a potential rebrand in the event of infringement, has made selecting a trademark trickier than ever. Christina Martini and Virginia Wolk Marino of DLA Piper report. 19 November 2015
Americas
Law firm BakerHostetler has hired Benjamin Hsing as a partner in the firm’s intellectual property group in New York. 19 November 2015
Pharma
Biopharmaceutical company Celgene has finally found success in fending off a challenge to one of its patents from Kyle Bass’s organisation the Coalition for Affordable Drugs. 17 November 2015
Americas
The US Court of Appeals for the Federal Circuit will consider en banc whether a “supplier exception” should be included in laws that prevent the patenting of inventions that have already been on sale. 16 November 2015
Americas
Law firm Wolf Greenfield has hired Jeffrey Hsi as a shareholder in its pharmaceutical practice. 16 November 2015
Pharma
The patentability of any claims directed to the use of CRISPR technology in human embryo-like structures and human reproductive cells is far from certain, as Duncan Ribbons and Maeve Lynch of Redd explain. 12 November 2015